FDA REFORM DEBATE MAY SPUR "MORE INFORMED" OVERSIGHT OF FDA BY CONGRESS, SENATE STAFFER SAYS; PDUFA REAUTHORIZATION SETS 5-YEAR CYCLE FOR FD&C ACT REVIEW

The Prescription Drug User Fee Act reauthorization under the FDA Modernization Act of 1997 has established a "five-year cycle" for review of the FD&C Act, Senate Labor & Human Resources Committee Health Policy Advisor Jay Hawkins told the annual Food & Drug Law Institute meeting Dec. 9 in Washington, D.C.